Abstract

Uncertainty remains about the association of potassium (K) intake with depression and anxiety status. We explored their relationship using 24-h urinary K, reflecting K intake, in general population. We collected 24-h urine and performed self-rating depression and anxiety scales (SDS, SAS) cross-sectionally in adults selected by random sampling in China. SDS and SAS standard score ≥50 defined depression and anxiety status. Participants were divided into three groups (T1, T2, and T3) by 24-h urinary K tertile. Odds ratios (OR) and 95% confidence intervals were calculated. Sensitivity analysis was performed by excluding anti-hypertensive agent takers. 546 participants comprised current analytical sample. First, T1 and T2 groups showed higher SDS scores (40.0vs 40.0vs 36.0, p=.001), prevalence (19.8vs 15.9vs 7.1%, p=.002), whereas increased adjusted odds for depression status only in T1 group (OR=2.71, p=.017), compared with T3 group. Second, T1 and T2 groups showed higher SAS scores (38.0vs 40vs 35.0, p<.001) and prevalence (14.8vs 21.4vs 8.8%, p=.003), whereas increased adjusted odds for anxiety status only in T2 group (OR=2.07, p=.042), compared with T3 groups. Third, T1 and T2 groups showed higher prevalence (10.4%vs 11.5%vs 2.7%, p=.004) and adjusted odds (OR=3.71, p=.013; OR=3.66, p=.014) for co-existent anxiety and depression status, compared with T3 group. Most results remained consistent in sensitivity analysis. Lower K intake is implicated in presence of anxiety and depression status in general population; this may provide basis for programs to increase K intake and prevent disease.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call